1. Dhaliwal G. Clinical excellence: make it a habit. Acad Med 2012;87:1473.
2. Durso SC, Christmas C, Kravet SJ, et al. Implications of academic medicine’s failure to recognize clinical excellence. Clin Med Res 2009;7:127-133.
3. Wright SM, Kravet S, Christmas C, et al. Creating an academy of clinical excellence at Johns Hopkins Bayview Medical Center: a 3-year experience. Acad Med 2010;85:1833-839.
4. Grigsby RK, Thorndyke L. Perspective: recognizing and rewarding clinical scholarship. Acad Med 2011;86:127-131.
5. Christmas C, Kravet SJ, Durso SC, et al. Clinical excellence in academia: perspectives from masterful academic clinicians. Mayo Clin Proc 2008;83:989-994.
6. Ziegelstein RC. Clinical excellence in cardiology. Am J Cardiol 2011;108:607-611.
7. Alfonso V, Geller J, Bermbach N, et al. Becoming a ‘‘treatment success’’: what helps and what hinders patients from achieving and sustaining undetectable viral loads. AIDS Patient Care STDS 2006;20:326-334.
8. Sidat M, Fairley C, Grierson J. Experiences and perceptions of patients with 100% adherence to highly active antiretroviral therapy: a qualitative study. AIDS Patient Care STDS 2007;21:509-520.
8a. Smith DK, Herbst JH, Zhang X, et al. Condom effectiveness for HIV prevention by consistency of use among men who have sex with men in the United States. J Acquir Immune Defic Syndr 2015;68:337-344.
9. Schneider J, Kaplan SH, Greenfield S, et al. Better physician-patient relationships are associated with higher reported adherence to antiretroviral therapy in patients with HIV infection. J Gen Intern Med 2004;19:1096-103.
10. Kinsler JJ, Wong MD, Sayles JN, et al. The effect of perceived stigma from a health care provider on access to care among a low-income HIVpositive population. AIDS Patient Care STDS 2007;21:584-592.
11. Dang BN, Westbrook RA, Black WC, et al. Examining the link between patient satisfaction and adherence to HIV care: a structural equation model. PLoS One 2013;8:e54729.
12. Lucas GM, Cheever LW, Chaisson RE, et al. Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection. J Acquir Immune Defic Syndr 2001;27:251Y-259.
13. Fiellin DA, Weiss L, Botsko M, et al. Drug treatment outcomes among HIV-infected opioid-dependent patients receiving buprenorphine/naloxone. J Acquir Immune Defic Syndr 2011;56(Suppl 1):S33-S38.
14. Soeffing JM, Martin LD, Fingerhood MI, et al. Buprenorphine maintenance treatment in a primary care setting: outcomes at 1 year. J Subst Abuse Treat 2009;37:426-430.
15. Hoang T, Goetz MB, Yano EM, et al. The impact of integrated HIV care on patient health outcomes. Med Care 2009;47:560-567.
16. Allen CM, Al-Jahdali HH, Irion KL, et al. Imaging lung manifestations of HIV/AIDS. Ann Thorac Med 2010;5:201-216. .
17. Kremer H, Ironson G. To tell or not to tell: why people with HIV share or don’t share with their physicians whether they are taking their medications as prescribed. AIDS Care 2006;18:520-528.
18. Stone VE. Strategies for optimizing adherence to highly active antiretroviral therapy: lessons from research and clinical practice. Clin Infect Dis 2001;33:865-872.
20. Roberts KJ. Physician-patient relationships, patient satisfaction, and antiretroviral medication adherence among HIV-infected adults attending a public health clinic. AIDS Patient Care STDS 2002;16:43-50.
21. Schilder AJ, Kennedy C, Goldstone IL, et al. ‘‘Being dealt with as a whole person.’’. Care seeking and adherence: the benefits of culturally competent care. Soc Sci Med 2001;52:1643-1659.